In November 2022, Biocon Limited, an innovation-driven global biopharmaceutical company, signed a semi-exclusive partnership agreement with Zentiva, a leading European pharmaceutical company, to commercialize Liraglutide, a vertically integrated, complex formulation for the treatment and management of Type 2 diabetes and obesity
Lastly, drug interactions and comorbidities may blunt the effects of therapy
Mutation of genes affecting the RAS pathway is common in childhood acute lymphoblastic leukemia
GLP-1RAs can be categorised based on molecular size, chemical structure and duration of action
20 Furthermore, the results remained consistent across subgroup and sensitivity analyses, indicating no variation in DR incidence or progression
17(36):4462-81 Melatonin: An Established Antioxidant Worthy of Use in Clinical Trials Ahmet Korkmaz, et al Mol Med 2009 Jan-Feb